Head-to-head dispatch
FitRx vs Roen Rx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance.
Marked down on: Insurance coordination may not work for all plans
FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.
Desk Score
Roen Rx offers compounded semaglutide as well as brand-name Ozempic, Wegovy, Zepbound, and Mounjaro with insurance coordination.
Marked down on: State availability not publicly disclosed
FDAWarning letter issued to Roen Health, Inc. dba RoenRx in June 2026. See the FDA warning-letter database.
FitRx takes this head-to-head with the higher Desk Score, 76/100 (C) against 63/100 (C) for Roen Rx. Roen Rx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
FitRx
76/100
C
Roen Rx
63/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | FitRx | Roen Rx |
|---|---|---|
| Semaglutide | $151/mo (quarterly plan, compounded) | $151/mo (3-month plan, plus a separate fee, compounded) |
| Tirzepatide | Not disclosed | $216/mo (plus a separate fee, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want insured patients seeking brand-name GLP-1 access with compounded fallback. | Patients with insurance seeking brand-name GLP-1 access with compounded fallback. |
| Desk Score | 76/100C | 63/100C |
The verdict
Desk pick — FitRxFitRx takes this head-to-head with the higher Desk Score, 76/100 (C) against 63/100 (C) for Roen Rx. Roen Rx still holds its ground where its strengths line up with yours.
Choose FitRx if…
Readers who want insured patients seeking brand-name GLP-1 access with compounded fallback.
$151/mo (quarterly plan, compounded) sema · Not disclosed tirz · All 50 states
FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.
Choose Roen Rx if…
Patients with insurance seeking brand-name GLP-1 access with compounded fallback.
$151/mo (3-month plan, plus a separate fee, compounded) sema · $216/mo (plus a separate fee, compounded) tirz · Coverage not published
FDAWarning letter issued to Roen Health, Inc. dba RoenRx in June 2026. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: FitRx · Roen Rx.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- FitRx vs CoreAge Rx
- Roen Rx vs Vaylen
- FitRx vs Strut Health
- Roen Rx vs Ondra Health
- FitRx vs Invigor Medical
- Roen Rx vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.